Literature DB >> 2083138

Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.

Y Kuwabara1, Y Ichiya, M Otsuka, T Tahara, T Fukumura, R Gunasekera, A Ichimiya, K Masuda.   

Abstract

We compared I-123 IMP and 99m-Tc HMPAO SPECT studies with 0-15 H2O and F-18 FDG PET studies, and evaluated the clinical significance of SPECT studies in dementia. Seventeen patients including 9 patients with Alzheimer's disease, 3 patients with Pick's disease and 5 patients with multi-infarct dementia were studied. IMP and HMPAO SPECT studies could not detect mildly affected areas when compared with FDG PET. However, they revealed decreased perfusion in the bilateral parietal regions in Alzheimer's disease and in the bilateral frontal regions in Pick's disease, while MRI and/or CT showed mild to moderate cerebral atrophy. IMP and HMPAO SPECT studies can be easily performed in clinical practice, and these findings were useful in the differential diagnosis of dementia. Our preliminary results suggested that SPECT studies with I-123 IMP and Tc-99m HMPAO, despite their limitations, are useful in the differential diagnosis of dementia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2083138     DOI: 10.1007/BF03164600

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  22 in total

1.  The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

Authors:  M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; E Hoffman; A Alavi; P Som; L Sokoloff
Journal:  Circ Res       Date:  1979-01       Impact factor: 17.367

2.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

3.  Positron emission tomography and histopathology in Pick's disease.

Authors:  H Kamo; P L McGeer; R Harrop; E G McGeer; D B Calne; W R Martin; B D Pate
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

4.  Cerebral blood flow with the continuous infusion of oxygen-15-labeled water.

Authors:  S C Jones; J H Greenberg; R Dann; G D Robinson; M Kushner; A Alavi; M Reivich
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

5.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

6.  A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; J A Besson; K P Ebmeier; F W Smith
Journal:  Eur J Nucl Med       Date:  1988

7.  The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia.

Authors:  H J Testa; J S Snowden; D Neary; R A Shields; A W Burjan; M C Prescott; B Northen; P Goulding
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

8.  Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

Authors:  H G Gemmell; P F Sharp; J A Besson; J R Crawford; K P Ebmeier; J Davidson; F W Smith
Journal:  J Comput Assist Tomogr       Date:  1987 May-Jun       Impact factor: 1.826

9.  Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

Authors:  J V Haxby; C L Grady; R Duara; N Schlageter; G Berg; S I Rapoport
Journal:  Arch Neurol       Date:  1986-09

10.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  3 in total

1.  Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.

Authors:  G Waldemar; P Bruhn; M Kristensen; A Johnsen; O B Paulson; N A Lassen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

2.  Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease.

Authors:  M Grossman; F Payer; K Onishi; T White-Devine; D Morrison; M D'Esposito; K Robinson; A Alavi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

Review 3.  Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?

Authors:  Rodolfo Ferrando; Andres Damian
Journal:  Front Neurol       Date:  2021-05-10       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.